| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.25 | 0.1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |